Diagnostic Approach to Infectious Mononucleosis

Diagnostic Value and Limitations

A positive Monospot test is diagnostic for Epstein-Barr virus (EBV) infection, but a negative result requires further testing due to false negatives in up to 10% of cases, particularly in children 1, 2
The Monospot test detects heterophile antibodies that develop during EBV infection, making it a useful first-line diagnostic tool for infectious mononucleosis 3
False-negative results occur in approximately 10% of cases, most commonly in children younger than 10 years 3, 4
False-positive results may occur in patients with leukemia, pancreatic carcinoma, viral hepatitis, or CMV infection 3, 4

When the Monospot test is positive, consider the diagnosis confirmed for EBV infection, and no further EBV-specific testing is required 1, 2, 3
When the Monospot test is negative but clinical suspicion remains high, perform EBV-specific serologic testing using the same sample that yielded the negative Monospot 1, 3
Test for IgG and IgM antibodies to viral capsid antigen (VCA) and antibodies to Epstein-Barr nuclear antigen (EBNA) to interpret EBV-specific serology 3, 4
Recent primary EBV infection is indicated by VCA IgM positive (with or without VCA IgG) and EBNA antibodies negative, while past infection is indicated by EBNA antibodies present 3, 4

Relying solely on a negative Monospot test to rule out infectious mononucleosis, especially in children, can lead to misdiagnosis 1
Failing to consider EBV-specific serologic testing when clinical suspicion is high despite a negative Monospot can delay diagnosis 3
Not recognizing that heterophile antibodies may take time to develop, potentially requiring repeat testing, can lead to false-negative results 1, 3